Our group previously identified tadalafil as a new PRMT5 inhibitor that effectively improves the sensitivity of tumor cells to doxorubicin and other chemotherapeutic drugs in breast cancer, providing new insights into breast cancer treatment [27]. Here, PRMT5 is linked to breast carcinoma.